Online HML - May 2022


You are viewing May 2022. View April 2022 Schedule.

Protein-Tyrosine Kinase Inhibitors

Imatinib mesilate         

/\ Tab 100 mg

Glivec 2123606 $2400.00 per 60

Cap 100 mg - 1% DV Jun-21 to 2023 (HSS)

Imatinib-Rex 2594315 $58.23 per 60

Cap 400 mg - 1% DV Jun-21 to 2023 (HSS)

Imatinib-Rex 2594323 $84.79 per 30

The Glivec brand of imatinib mesilate (supplied by Novartis) is fully subsidised under Special Authority for patients with unresectable and/or metastatic malignant GIST only, see SA1460 in Section B of the Pharmaceutical Schedule